Document is current
Any future updates will be listed below
-
Authors
Koeken, Ine
Walravens, Magali
Fernández-Acosta, Roberto https://orcid.org/0000-0002-1588-9231
Van Hoyweghen, Ruben
Vintea, Iuliana
Kong, Yingyi
Golba, Bianka
Dehairs, Jonas
Talebi, Ali https://orcid.org/0000-0003-2601-2686
Swinnen, Johannes V. https://orcid.org/0000-0002-7720-5077
Durinck, Kaat https://orcid.org/0000-0003-1762-5739
Mañas, Adriana https://orcid.org/0000-0002-6955-1754
Toyokuni, Shinya
Menschaert, Gerben
Fedorova, Maria
De Geest, Bruno G.
Hassannia, Behrouz
Vanden Berghe, Tom https://orcid.org/0000-0002-1633-0974
- License Information
-
More Information
Article History
Received: 6 June 2025
Revised: 21 October 2025
Accepted: 12 November 2025
First Online: 26 November 2025
Competing interests
: TVB owns patents related to ferroptosis inhibitors and is the founder of FiriX Therapeutics.
